Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr-Jun;16(2):96-101.

Effect of Administration of Single Dose GnRH Agonist in Luteal Phase on Outcome of ICSI-ET Cycles in Women with Previous History of IVF/ICSI Failure: A Randomized Controlled Trial

Simin Zafardoust  1 , Mahmood Jeddi-Tehrani  2 , Mohammad Mehdi Akhondi  1 , Mohammad Reza Sadeghi  2 , Koroush Kamali  1 , Sara Mokhtar  1 , Bita Badehnoosh  1 , Fatemeh Arjmand-Teymouri  1 , Farnaz Fatemi  1 , Afsaneh Mohammadzadeh  1
Affiliations

Effect of Administration of Single Dose GnRH Agonist in Luteal Phase on Outcome of ICSI-ET Cycles in Women with Previous History of IVF/ICSI Failure: A Randomized Controlled Trial

Simin Zafardoust et al. J Reprod Infertil. 2015 Apr-Jun.

Abstract

Background: GnRH agonist administration in the luteal phase has been suggested to beneficially affect the outcome of intracytoplasmic sperm injection (ICSI) and embryo transfer (ET) cycles. This blind randomized controlled study evaluates the effect of GnRH (Gonadotropine Releasing Hormone) agonist administration on ICSI outcome in GnRH antagonist ovarian stimulation protocol in women with 2 or more previous IVF/ICSI-ET failures.

Methods: One hundred IVF failure women who underwent ICSI cycles and stimulated with GnRH antagonist ovarian stimulation protocol, were included in the study. Women were randomly assigned to intervention (received a single dose injection of GnRH agonist (0.1 mg of Decapeptil) subcutaneously 6 days after oocyte retrieval) and control (did not receive GnRH agonist) groups. Implantation and clinical pregnancy rates were the primary outcome measures.

Results: Although the age of women, the number of embryos transferred in the current cycle and the quality of the transferred embryos were similar in the two groups, there was a significantly higher rate of implantation (Mann Whitney test, p = 0.041) and pregnancy (32.6% vs. 12.5%, p = 0.030, OR = 3.3, 95%CI, 1.08 to 10.4) in the intervention group.

Conclusion: Our results suggested that, in addition to routine luteal phase support using progesterone, administration of 0.1 mg of Decapeptil 6 days after oocyte retrieval in women with previous history of 2 or more IVF/ICSI failures led to a significant improvement in implantation and pregnancy rates after ICSI following ovarian stimulation with GnRH antagonist protocol.

Keywords: Decapeptil; GnRH agonist; GnRH antagonist; ICSI; IVF failure; Implantation failure; Intracytoplasmic sperm injection; Luteal phase support.

PubMed Disclaimer

References

    1. Jindal UN, Verma S, editors. Luteal Phase Support. London-United Kingdom: Jaypee Brothers; 2013. p. 622. (Rao KA, Carp HJA, Fischer F. Textbook of In Vitro Fertilization; vol. 2)
    1. Aflatoonian A, Asgharnia M, Alshohadaei FS. Comparison of progesterone administration before and after embryo transfer in ART cycles. J Reprod Infertil. 2004;5(1):44–51.
    1. Smitz J, Devroey P, Camus M, Deschacht J, Khan I, Staessen C, et al. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. Hum Reprod. 1988;3(5):585–90. - PubMed
    1. Van Steirteghem AC, Smitz J, Camus M, Van Waesberghe L, Deschacht J, Khan I, et al. The luteal phase after in-vitro fertilization and related procedures. Hum Reprod. 1988;3(2):161–4. - PubMed
    1. Devroey P, Bourgain C, Macklon NS, Fauser BC. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab. 2004;15(2):84–90. - PubMed

LinkOut - more resources